China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) Cash Flow Statement
A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in the People's Republic of China and internationally.
Total Cash From Operating Activities Chart for China Resources Sanjiu Medical & Pharmaceutical Co Ltd
China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) operating cash flow for FY2025 was CNY 5.5B, a 25.2% change from FY2024. China Resources Sanjiu Medical & Pharmaceutical Co Ltd's operating cash flow grew from CNY 120.6M in 1999 to CNY 5.5B in 2025 (4470.3% over 26 years). Operating cash flow compound annual growth rate: 5-year CAGR of 19.9%, 10-year CAGR of 15.9%, 20-year CAGR of 31.6%.
Total Cash From Operating Activities (CNY)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- ¥40.59B
- Implied Share Price
- ¥24.39
- Enterprise Value
- ¥38.28B
- Revenue (TTM)
- ¥31.81B
- EBITDA
- ¥5.32B
- Profit Margin
- 10.30%
- Trailing P/E
- 12.38
- Forward P/E
- 16.47
- Price/Book (MRQ)
- 1.80
- Price/Sales (TTM)
- 1.28
- EV/EBITDA
- 5.97
- EV/Revenue
- 1.20
- Dividend Yield
- 4.08%
- Book Value
- ¥13.72
- Free Cash Flow (FY2025)
- ¥4.24B
- Free Cash Flow Yield
- 10.45%
Snapshot as of 28th August 2026 — not point-in-time controlled, may lag the live market by a few days.